TEVA PHARMACEUT. SP.ADRTEVA PHARMACEUT. SP.ADRTEVA PHARMACEUT. SP.ADR

TEVA PHARMACEUT. SP.ADR

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
0.47EUR
Revenue estimate
‪3.46 B‬EUR
Market capitalization
‪13.52 B‬EUR
−0.45EUR
‪−506.46 M‬EUR
‪14.36 B‬EUR
‪1.12 B‬
Beta (1Y)
0.57

About TEVA PHARMACEUT. SP.ADR

CEO
Richard Francis
Headquarters
Tel Aviv
Employees (FY)
‪37.23 K‬
Founded
1901
FIGI
BBG000D86Q21
Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.